All clinical trials have only used the Patented Microencapsulated BioResponse DIM Formulation, including clinical trials sponsored by the National Cancer Institute.
Clinical trials are currently underway using BioResponse DIM in collaboration with Cornell University, the NYU School of Medicine, Cancer Research UK, Wayne State University, and New York Medical College. BioResponse Nutrients works with the National Cancer Institute (NCI) under a clinical trials agreement to discover the further health potential of DIM.
Please visit ClinicalTrials.gov for a listing of Clinical Trials using Microencapsulated DIM. |
